Thyrogen Den Europæiske Union - dansk - EMA (European Medicines Agency)

thyrogen

sanofi b.v. - thyrotropin alfa - thyroid neoplasms - hypofyseforlaps lap hormoner og analoger, hypofyse og hypothalamus hormoner og analoger - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Renagel Den Europæiske Union - dansk - EMA (European Medicines Agency)

renagel

sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - alle andre terapeutiske produkter - renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Tasermity Den Europæiske Union - dansk - EMA (European Medicines Agency)

tasermity

genzyme europe bv - sevelamer hydrochlorid - hyperphosphatemia; renal dialysis - alle andre terapeutiske produkter - tasermitet er indiceret til bekæmpelse af hyperphosphatæmi hos voksne patienter, der modtager hæmodialyse eller peritonealdialyse. sevelamer hydrochlorid bør anvendes inden for rammerne af en flere terapeutiske tilgang, som kunne omfatte kalktilskud, 1,25 dihydroxy vitamin d3 eller et af dets analoger til at styre udviklingen af renal knoglesygdom.

Alendronat "Aurobindo" 70 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

alendronat "aurobindo" 70 mg tabletter

aurobindo pharma (malta) limited - natriumalendronate, vandfrit - tabletter - 70 mg

Amlodipin "Aurobindo" 5 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

amlodipin "aurobindo" 5 mg tabletter

aurobindo pharma (malta) limited - amlodipinbesilat - tabletter - 5 mg

Amlodipin/valsartan "Stada" 5/80 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

amlodipin/valsartan "stada" 5/80 mg filmovertrukne tabletter

stada arzneimittel ag - amlodipinbesilat, valsartan - filmovertrukne tabletter - 5/80 mg

Amoxicillin/clavulansyre "Aurobindo" 500 mg+125 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

amoxicillin/clavulansyre "aurobindo" 500 mg+125 mg filmovertrukne tabletter

aurobindo pharma (malta) limited - amoxicillintrihydrat, kaliumclavulanat - filmovertrukne tabletter - 500 mg+125 mg

Aquacycline Vet. 100 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aquacycline vet. 100 mg/ml injektionsvæske, opløsning

ceva animal health a/s - oxytetracyclin, vandfrit, oxytetracyclinhydrochlorid - injektionsvæske, opløsning - 100 mg/ml - får, hest, kvæg, svin

Aquacycline Vet. 180 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aquacycline vet. 180 mg/ml injektionsvæske, opløsning

ceva santé animale - oxytetracyclin, vandfrit, oxytetracyclinhydrochlorid - injektionsvæske, opløsning - 180 mg/ml - får, kvæg, svin